JPRN-jRCTs021210048招募中2 期
The preventive effect of Ninjin'yoeito on sarcopenia among patients with advanced urotherial carcinoma who received systemic chemotherapy (A single-center, single-arm, open-label trial)
Okamoto Teppei0 个研究点目标入组 30 人开始时间: 2021年11月18日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 65age old 至 < 90age old（—）
- 性别
- All
入选标准
- •1. Patients with advanced urothelial carcinoma who recieve platinum-based chemotherapy (Age; 65-90 years)
- •2. Patients who understand and are willing to participate this study.
- •3. Patients without a severe general condition due to progressive disease.
- •4. Patients without an abnormality in liver function and serum potassium level.
- •5. Patients who do not take other harbal medicines which have supportive roles for cancer treatment.
排除标准
- •1. Patients can not take a harbal medicine due to dysphagia and/or tube feeding.
- •2. Patients who have already took other harbal medicines which have supportive roles for cancer treatment.
研究者
相似试验
尚未招募
不适用
The preventive effect of Ninjin'yoeito on sarcopenia among patients with advanced urotherial carcinoma who received systemic chemotherapy (A single-center, single-arm, open-label trial)Advanced urothelial carcinomaJPRN-UMIN000044092Hirosaki University hospital30
已完成
2 期
Preventive effect of shakuyaku-kanzo-to on neurotoxicity of FOLFOX plus bevacizumab for patients with metastatic colorectal cancer: a prospective phase II studyColorectal CancerJPRN-UMIN000001853niversity of Toyama40
招募中
不适用
Clinical investigation of ninjin'yoeito on the recovery phase of inpatients with acute illness.Inpatients with acute illnessJPRN-UMIN000035979Japanese Red Cross Kumamoto Hospital80
尚未招募
不适用
The effect of Yokukansan suppository to prevent emergence agitation after general anesthesia in pediatric patientsThe pediatric patients undergoing strabismus surgery or tonsillectomyJPRN-UMIN000026687Kanagawa children's medical centre100
招募中
2 期
Preventive effect of Goshajinkigan against CIPN with paclitaxel: an open-label, randomized, phase II studyJPRN-jRCTs061210047Makimoto Go66